pentoxifylline has been researched along with Escherichia coli Infections in 24 studies
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficiency of pentoxifylline (PTX), a methyl xanthine derivative, in preventing renal scar formation after the induction of pyelonephritis in an experimental rat model with delayed antimicrobial therapy." | 7.72 | Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. ( Boleken, ME; Dindar, H; Ertoy, D; Gokcora, IH; Ozsan, M; Yagmurlu, A, 2003) |
| "The aim of this study was to investigate whether the methylxanthine-derivative pentoxifylline (PTX) affects bacterial clearance of the organism in states of hemorrhage and endotoxemia." | 7.70 | Pentoxifylline improves bacterial clearance during hemorrhage and endotoxemia. ( Heller, A; Heller, S; Koch, T; Urbaschek, R; Weber, K, 1999) |
| "To compare effects of a single dose of pentoxifylline (PTX), flunixin meglumine (FM), and their combination (FM/PTX) in a model of equine endotoxemia." | 7.69 | Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. ( Anders, B; Barton, MH; Baskett, A; Moore, JN; Norton, N, 1997) |
| "Since fungal septic shock with acute disseminated candidiasis evolves prior to significant increases in circulating TNF, PTX also appears ineffective in its treatment." | 5.29 | Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. ( Lechner, AJ; Matuschak, GM; Potthoff, LH; Rouben, LR; Tredway, TL, 1993) |
| "To evaluate the efficiency of pentoxifylline (PTX), a methyl xanthine derivative, in preventing renal scar formation after the induction of pyelonephritis in an experimental rat model with delayed antimicrobial therapy." | 3.72 | Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. ( Boleken, ME; Dindar, H; Ertoy, D; Gokcora, IH; Ozsan, M; Yagmurlu, A, 2003) |
| "The aim of this study was to investigate whether the methylxanthine-derivative pentoxifylline (PTX) affects bacterial clearance of the organism in states of hemorrhage and endotoxemia." | 3.70 | Pentoxifylline improves bacterial clearance during hemorrhage and endotoxemia. ( Heller, A; Heller, S; Koch, T; Urbaschek, R; Weber, K, 1999) |
| "To compare effects of a single dose of pentoxifylline (PTX), flunixin meglumine (FM), and their combination (FM/PTX) in a model of equine endotoxemia." | 3.69 | Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. ( Anders, B; Barton, MH; Baskett, A; Moore, JN; Norton, N, 1997) |
| "The inhibitory effect of chlorpromazine (CPZ), pentoxifylline (PTX) and dexamethasone (DEX) was investigated in a model of endotoxin shock in Holstein calves following an intravenous administration of Esherichia coli endotoxin (LPS)." | 3.69 | Inhibitory effect on LPS-induced tumor necrosis factor in calves treated with chlorpromazine or pentoxifylline. ( Higuchi, T; Matsuzawa, H; Ohtsuka, H; Sato, H; Takahashi, J; Takahashi, K; Yoshino, TO, 1997) |
| "We postulated that PTX treatment in acute endotoxemia downregulates the inflammatory response and may decrease lung injury." | 1.33 | LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression. ( Coimbra, R; Hoyt, DB; Loomis, W; Melbostad, H; Porcides, RD; Tobar, M; Wolf, P, 2006) |
| "Since fungal septic shock with acute disseminated candidiasis evolves prior to significant increases in circulating TNF, PTX also appears ineffective in its treatment." | 1.29 | Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. ( Lechner, AJ; Matuschak, GM; Potthoff, LH; Rouben, LR; Tredway, TL, 1993) |
| "coli septicemia plus PTXF bolus 20 mg/kg injected 5 min before E." | 1.27 | Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. ( Harada, H; Hogue, RS; Ishizaka, A; O'Hanley, PT; Raffin, TA; Stephens, KE; Wu, ZH, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.67) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groesdonk, HV | 1 |
| Bauer, A | 1 |
| Kreft, B | 1 |
| Heringlake, M | 1 |
| Paarmann, H | 1 |
| Pagel, H | 1 |
| Oliveira-Júnior, IS | 2 |
| Oliveira, IS | 1 |
| Oliveira, WR | 1 |
| Cavassani, SS | 1 |
| Brunialti, MK | 2 |
| Salomao, R | 2 |
| Yagmurlu, A | 1 |
| Boleken, ME | 1 |
| Ertoy, D | 1 |
| Ozsan, M | 1 |
| Gokcora, IH | 1 |
| Dindar, H | 1 |
| Okayama, A | 1 |
| Mikasa, K | 1 |
| Matsui, N | 1 |
| Higashi, N | 1 |
| Miyamoto, M | 1 |
| Kita, E | 1 |
| Coimbra, R | 1 |
| Melbostad, H | 1 |
| Loomis, W | 1 |
| Porcides, RD | 1 |
| Wolf, P | 1 |
| Tobar, M | 1 |
| Hoyt, DB | 1 |
| Koh, IH | 1 |
| Junqueira, VB | 1 |
| Breuillé, D | 3 |
| Farge, MC | 1 |
| Rosé, F | 1 |
| Arnal, M | 1 |
| Attaix, D | 1 |
| Obled, C | 3 |
| Lechner, AJ | 1 |
| Rouben, LR | 1 |
| Potthoff, LH | 1 |
| Tredway, TL | 1 |
| Matuschak, GM | 1 |
| Krysztopik, RJ | 1 |
| Bentley, FR | 1 |
| Wilson, MA | 1 |
| Spain, DA | 1 |
| Garrison, RN | 1 |
| Santos, AA | 1 |
| Wilmore, DW | 1 |
| Bengtsson, A | 1 |
| Redl, H | 1 |
| Schlag, G | 1 |
| Mollnes, TE | 1 |
| Högåsen, K | 1 |
| Baskett, A | 1 |
| Barton, MH | 1 |
| Norton, N | 1 |
| Anders, B | 1 |
| Moore, JN | 1 |
| Ohtsuka, H | 1 |
| Higuchi, T | 1 |
| Matsuzawa, H | 1 |
| Sato, H | 1 |
| Takahashi, K | 1 |
| Takahashi, J | 1 |
| Yoshino, TO | 1 |
| Voisin, L | 2 |
| Ruot, B | 1 |
| Rallière, C | 1 |
| Rambourdin, F | 1 |
| Dalle, M | 1 |
| Heller, S | 1 |
| Weber, K | 1 |
| Heller, A | 1 |
| Urbaschek, R | 1 |
| Koch, T | 1 |
| Vary, T | 1 |
| Dardevet, D | 1 |
| Grizard, J | 1 |
| Buffiere, C | 1 |
| Denis, P | 1 |
| Mazolewski, PJ | 1 |
| Barber, A | 1 |
| Williams, S | 1 |
| Simoni, J | 1 |
| Davis, S | 1 |
| Shires, GT | 1 |
| Park, WS | 1 |
| Chang, YS | 1 |
| Lee, M | 1 |
| Hoffmann, H | 2 |
| Hatherill, JR | 3 |
| Crowley, J | 1 |
| Harada, H | 3 |
| Yonemaru, M | 3 |
| Zheng, H | 3 |
| Ishizaka, A | 4 |
| Raffin, TA | 4 |
| Chung, TW | 1 |
| O'Rear, EA | 2 |
| Whitsett, TL | 2 |
| Hinshaw, LB | 2 |
| Smith, MA | 1 |
| Mallick, AA | 1 |
| Lilly, CM | 1 |
| O'Hanley, PT | 2 |
| Fujishima, S | 1 |
| Wu, ZH | 1 |
| Stephens, KE | 1 |
| Hogue, RS | 1 |
| Puranapanda, V | 1 |
| Chang, AC | 1 |
1 trial available for pentoxifylline and Escherichia coli Infections
| Article | Year |
|---|---|
The systemic inflammatory response: perspective of human endotoxemia.
Topics: Body Temperature; Cytokines; Endotoxemia; Endotoxins; Escherichia coli Infections; Heart Rate; Human | 1996 |
23 other studies available for pentoxifylline and Escherichia coli Infections
| Article | Year |
|---|---|
Urodilatin and pentoxifylline prevent the early onset of Escherichia coli-induced acute renal failure in a model of isolated perfused rat kidney.
Topics: Acute Kidney Injury; Animals; Atrial Natriuretic Factor; Disease Models, Animal; Escherichia coli In | 2009 |
Effects of pentoxifylline on inflammation and lung dysfunction in ventilated septic animals.
Topics: Acute Disease; Analysis of Variance; Animals; Bronchoalveolar Lavage; Disease Models, Animal; Enzyme | 2010 |
Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis.
Topics: Acute Disease; Animals; Cicatrix; Disease Models, Animal; Escherichia coli; Escherichia coli Infecti | 2003 |
An interventional approach to block brain damage caused by Shiga toxin-producing Escherichia coli infection, by use of a combination of phosphodiesterase inhibitors.
Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Brain Diseases; Cecum; Cells, Cultured; Cytokines | 2004 |
LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression.
Topics: Animals; Disease Models, Animal; Endotoxemia; Escherichia coli Infections; Intercellular Adhesion Mo | 2006 |
Effect of pentoxifylline on lung inflammation and gas exchange in a sepsis-induced acute lung injury model.
Topics: Acute Disease; Animals; Disease Models, Animal; Escherichia coli Infections; Inflammation; Inflammat | 2006 |
Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis.
Topics: Animals; Eating; Escherichia coli Infections; Liver; Male; Muscle Proteins; Muscles; Pentoxifylline; | 1993 |
Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.
Topics: Animals; Bacteremia; Candidiasis; Escherichia coli Infections; Fungemia; Gene Expression; Male; Pent | 1993 |
Vasomotor response to pentoxifylline mediates improved renal blood flow to bacteremia.
Topics: Animals; Arterioles; Bacteremia; Blood Pressure; Cardiac Output; Escherichia coli Infections; Heart | 1996 |
Effects on complement activation and cytokine (TNF-alpha and IL-8) release of infusion of anti-TNF-antibodies or a xanthine derivative (HWA 138) in septic baboons.
Topics: Animals; Antibodies; Complement Activation; Complement Membrane Attack Complex; Escherichia coli Inf | 1996 |
Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal | 1997 |
Inhibitory effect on LPS-induced tumor necrosis factor in calves treated with chlorpromazine or pentoxifylline.
Topics: Animals; Cattle; Chlorpromazine; Dexamethasone; Endotoxins; Escherichia coli Infections; Female; Lip | 1997 |
Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats.
Topics: Acute-Phase Proteins; Animals; Escherichia coli Infections; Free Radical Scavengers; Interleukin-1; | 1998 |
Pentoxifylline improves bacterial clearance during hemorrhage and endotoxemia.
Topics: Animals; Bacteremia; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxins; Escherichia c | 1999 |
Pentoxifylline improves insulin action limiting skeletal muscle catabolism after infection.
Topics: Analysis of Variance; Animals; Culture Techniques; Escherichia coli Infections; Forelimb; Insulin; M | 1999 |
Attenuating tumor necrosis factor alpha does not ameliorate other cytokine and peroxidase products during sepsis.
Topics: Animals; Benzyl Compounds; Cytokines; Dexamethasone; Drug Combinations; Escherichia coli Infections; | 1999 |
The efficacy of pentoxifylline as an anti-inflammatory agent in experimental Escherichia coli meningitis in the newborn piglet.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Brain; Cerebral Cortex; Cerebrospinal Fluid; Co | 2000 |
Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs.
Topics: Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Bucladesine; Endotoxins; Escherichia coli; Es | 1991 |
Survival factors in a canine septic shock model.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dogs; Erythrocyte Deformability; Escherichia coli I | 1991 |
The effects of aminophylline and pentoxifylline on multiple organ damage after Escherichia coli sepsis.
Topics: Albumins; Aminophylline; Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Edema; Escherichia c | 1989 |
Attenuation of acute lung injury in septic guinea-pigs by a new xanthine derivative (HWA-138).
Topics: Acute Disease; Animals; Blood Pressure; Bronchodilator Agents; Erythrocytes; Escherichia coli Infect | 1989 |
Attenuation of acute lung injury in septic guinea pigs by pentoxifylline.
Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Escherichia coli Infections; Female; Glucuroni | 1988 |
Erythrocyte deformability in canine septic shock and the efficacy of pentoxifylline and a leukotriene antagonist.
Topics: Acetophenones; Animals; Azoles; Dogs; Erythrocyte Deformability; Escherichia coli Infections; Female | 1987 |